The DBT was also one of the world's first government departments that was established to focus solely on the biotechnology sector.
[14][15] Reliance Life Sciences, owned by Mukesh Ambani, Asia's wealthiest man, manufactures biosimilars and other biopharmaceutical and pharmaceutical products.
[24] Hester Biosciences is Asia’s largest company that manufactures animal and poultry vaccines.
[30] In 2021, Cipla entered into a joint venture with biopharmaceutical CDMO company Kemwell Biopharma, to develop, manufacture and commercialize biosimilars for global markets.
[31] Concord Biotech, among other areas, offers contract research and manufacturing services for fermentation products.
[32] Concord Biotech manufactures, among other products, fermentation based complex active pharmaceutical ingredients.
[39] The parks have been set up by the DBT to give infrastructure support that will assist in making biotechnology research into products and services.
[39] The biotechnology parks give scientists and small and medium-sized enterprises facilities that can help them in developing and demonstrating technologies, and assist in their pilot plant studies as well.